JP2022509354A5 - - Google Patents
Info
- Publication number
- JP2022509354A5 JP2022509354A5 JP2021547650A JP2021547650A JP2022509354A5 JP 2022509354 A5 JP2022509354 A5 JP 2022509354A5 JP 2021547650 A JP2021547650 A JP 2021547650A JP 2021547650 A JP2021547650 A JP 2021547650A JP 2022509354 A5 JP2022509354 A5 JP 2022509354A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- pharmaceutical composition
- item
- weight
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862749446P | 2018-10-23 | 2018-10-23 | |
| US62/749,446 | 2018-10-23 | ||
| PCT/US2019/057722 WO2020086759A2 (en) | 2018-10-23 | 2019-10-23 | Composition and method for treating the lungs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022509354A JP2022509354A (ja) | 2022-01-20 |
| JP2022509354A5 true JP2022509354A5 (https=) | 2022-10-31 |
Family
ID=70331261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547650A Ceased JP2022509354A (ja) | 2018-10-23 | 2019-10-23 | 肺を処置するための組成物および方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220000966A1 (https=) |
| EP (1) | EP3869985A4 (https=) |
| JP (1) | JP2022509354A (https=) |
| KR (1) | KR20210119376A (https=) |
| CN (2) | CN113365513B (https=) |
| AU (1) | AU2019365216A1 (https=) |
| BR (1) | BR112021007692A2 (https=) |
| CA (1) | CA3117213A1 (https=) |
| IL (1) | IL282600A (https=) |
| MX (1) | MX2021004692A (https=) |
| SG (1) | SG11202104158SA (https=) |
| WO (1) | WO2020086759A2 (https=) |
| ZA (1) | ZA202103404B (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230117644A (ko) | 2016-11-17 | 2023-08-08 | 레노비온, 아이엔씨. | 글루타티온 조성물에 의한 호흡기 질환 및 감염 치료 |
| ES3008699T3 (en) | 2017-11-17 | 2025-03-24 | Renovion Inc | Stable ascorbic acid compositions and methods of using the same |
| WO2021146662A1 (en) * | 2020-01-17 | 2021-07-22 | Muhammed Majeed | Therapeutic compositions and methods for pulmonary fibrosis |
| EP4146188A4 (en) * | 2020-05-08 | 2024-06-19 | Theaprin Pharmaceuticals Inc. | COCRYSTALLINE ANTIOXIDANTS OF PROTOCATECHIC ACID WITH L-THEANINE FOR THE TREATMENT OF OXIDATIVE STRESS AND INFLAMMATORY DISEASES |
| WO2021245655A1 (en) * | 2020-05-31 | 2021-12-09 | Roxx Labs Ltd. | Compositions comprising cannabinoids and volatile anesthetics for inhalation and anti-viral uses thereof |
| EP4167989A4 (en) * | 2020-06-19 | 2024-07-03 | Peter Hofleitner | COMPOSITION FOR THE TREATMENT OF VIRUS INFECTIONS |
| EP3949964A1 (en) * | 2020-08-06 | 2022-02-09 | Nuvamid SA | Combination of nicotinamide mononucleotide derivatives and other therapeutic agents for use in the treatment of viral infections |
| WO2022029275A1 (en) * | 2020-08-06 | 2022-02-10 | Nuvamid Sa | Combination of nicotinamide mononucleotide derivatives and other therapeutic agents for use in the treatment of coronavirus infections and covid-19 |
| WO2023285984A1 (en) * | 2021-07-14 | 2023-01-19 | Redox-Co S.R.L. | Glutahtione c4 against airway affections |
| IL313997A (en) | 2022-01-04 | 2024-08-01 | Renovion Inc | Aqueous solution including glutathione salt |
| WO2023210481A1 (ja) * | 2022-04-28 | 2023-11-02 | 学校法人近畿大学 | カリオフィレン含有組成物 |
| WO2023233183A1 (en) * | 2022-06-01 | 2023-12-07 | VOLPI, Simone | Pharmaceutical compositions for treating neurological diseases |
| CN117205319B (zh) * | 2022-06-02 | 2024-09-03 | 中国人民解放军军事科学院军事医学研究院 | Hc030031在制备预防或治疗百草枯中毒引起的肺损伤的药物中的应用 |
| CN114903995B (zh) * | 2022-06-02 | 2023-07-28 | 中国人民解放军军事科学院军事医学研究院 | Trpa1离子通道作为药物靶点在酰胺类除草剂中毒中的应用 |
| WO2024016019A1 (en) * | 2022-07-15 | 2024-01-18 | Renovion, Inc. | Compositions and methods for treatment of subjects suffering from a sars-cov-2 infection |
| WO2024025525A1 (en) * | 2022-07-27 | 2024-02-01 | Medterra Pharma Llc | Cannabinoid compositions and methods of using for the treatment of non-eosinophilic inflammation and inflammatory disorders |
| CN117679423A (zh) * | 2022-09-05 | 2024-03-12 | 立生医药(苏州)有限公司 | 预防或治疗呼吸系统疾病的吸入用药物组合物 |
| CN117981896A (zh) * | 2022-10-28 | 2024-05-07 | 思摩尔国际控股有限公司 | 复合烟碱盐、复合烟碱盐调配物及其制备方法和应用 |
| CN120265283A (zh) * | 2022-11-24 | 2025-07-04 | 长风药业股份有限公司 | (-)-表没食子儿茶素没食子酸酯类化合物的应用 |
| CN115813011A (zh) * | 2022-12-30 | 2023-03-21 | 东莞市吉纯生物技术有限公司 | 一种具有茶氨酸的雾化液的制备方法与应用 |
| WO2024161313A1 (en) * | 2023-01-31 | 2024-08-08 | Rai Strategic Holdings, Inc. | Stabilized aerosol precursor formulations |
| CN115998758B (zh) * | 2023-03-01 | 2024-04-19 | 中国药科大学 | 甲钴胺及药物组合物在制备用于治疗肝衰竭药物中的应用 |
| CN121001726A (zh) * | 2023-03-01 | 2025-11-21 | 里格尔药品股份有限公司 | Syk抑制剂用于治疗化学或辐射诱导的肺损伤的用途 |
| KR102745803B1 (ko) * | 2023-07-28 | 2024-12-24 | 주식회사 배젠 | 호두 분쇄 추출물을 이용한 폐질환 치료용 조성물 및 이의 치료용 용도 |
| TWI872951B (zh) * | 2024-02-19 | 2025-02-11 | 高雄醫學大學 | 用於治療、預防或減輕肺功能損傷之類黃酮藥物 |
| WO2025231041A1 (en) * | 2024-04-30 | 2025-11-06 | Renovion, Inc. | Methods for reducing symptoms in subjects suffering from bronchiectasis and other pulmonary diseases |
| JP7649095B1 (ja) * | 2024-10-07 | 2025-03-19 | 日本たばこ産業株式会社 | 自己乳化組成物 |
| CN119015390B (zh) * | 2024-10-29 | 2025-03-28 | 江西中医药大学附属医院 | 一种治疗慢性咳嗽的中药脐贴及其制备方法 |
| CN119385331A (zh) * | 2024-12-05 | 2025-02-07 | 河南中烟工业有限责任公司 | 一种功能型特色再造烟叶的制备及应用 |
| CN120123897B (zh) * | 2025-03-11 | 2026-04-03 | 广东海洋大学 | 一种育珠贝生长环境监测方法及系统 |
| CN120284942B (zh) * | 2025-04-22 | 2025-12-16 | 西南医科大学附属中医医院 | 桑辛素类化合物在制备治疗慢性肾脏病的药物中的用途 |
| CN121775153A (zh) * | 2026-03-05 | 2026-04-03 | 四川大学华西医院 | 多酚/胺复合物、肺靶向递送系统及其构建方法及应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5238683A (en) * | 1989-11-24 | 1993-08-24 | The United States Of America As Represented By The Department Of Health And Human Services | Aerosol preparation of glutathione and a method for augmenting glutathione level in lungs |
| DE69124223T2 (de) * | 1990-02-05 | 1997-04-30 | Lifescience Corp | Vitamine und mineralien enthaltende nahrungszusätze |
| US7045152B2 (en) * | 1999-09-08 | 2006-05-16 | Duke University | Treating pulmonary disorders with gaseous agent causing repletion of GSNO |
| AU2003223718B2 (en) * | 2002-04-25 | 2007-08-16 | The Scripps Research Institute | Treatment and prevention of pulmonary conditions |
| ATE530165T1 (de) * | 2003-11-14 | 2011-11-15 | Baxter Int | Alpha1-antitrypsin-zusammensetzungen und behandlungsverfahren unter verwendung dieser zusammensetzungen |
| JP2009537570A (ja) * | 2006-05-18 | 2009-10-29 | ティカ レーケメデル アーベー | アルブテロールの吸入可能溶液を有する単位用量製剤 |
| US20080066739A1 (en) * | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
| US20090169487A1 (en) * | 2007-12-28 | 2009-07-02 | Hedayat Kamyar Malek | Essential Oil Diffusion |
| PE20140234A1 (es) * | 2010-12-20 | 2014-03-08 | Glenmark Phamaceuticals S A | Compuestos de 2-amino-4-ariltiazol como antagonistas de trpa1 |
| CA2836856A1 (en) * | 2011-06-13 | 2012-12-20 | Glenmark Pharmaceuticals, S.A. | Treatment of respiratory disorders using trpa1 antagonists |
| US20140148423A1 (en) * | 2011-07-25 | 2014-05-29 | Glenmark Pharmaceuticals S.A. | Pharmaceutical composition comprising a trpa1 antagonist and a steroid |
| JP5979931B2 (ja) * | 2012-03-22 | 2016-08-31 | 小林製薬株式会社 | 医薬組成物 |
| BR112015006571A2 (pt) * | 2012-10-23 | 2017-07-04 | Cipla Ltd | composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição farmacêutica, e, método para a profilaxia ou tratamento de asma, doença pulmonar obstrutiva crônica e distúrbios respiratórios relacionados |
| HUE052275T2 (hu) * | 2013-01-28 | 2021-04-28 | Incozen Therapeutics Pvt Ltd | Eljárások autoimmun, légzõszervi és gyulladásos rendellenességek kezelésére roflumilaszt N-oxid inhalálásával |
| TWI676626B (zh) * | 2014-04-23 | 2019-11-11 | 美商美國禮來大藥廠 | 抑制瞬時受體電位ａ１離子通道 |
| AU2015308546A1 (en) * | 2014-08-25 | 2017-04-13 | Clk Consult V/ Carsten Leonhard Knudsen | Device with compositions for delivery to the lungs, the oral mucosa and the brain |
| US9867779B2 (en) * | 2015-03-26 | 2018-01-16 | Patheon Softgels Inc. | Liquisoft capsules |
| CN108697665A (zh) * | 2015-09-30 | 2018-10-23 | 乔治·爱德华·霍格 | 局部镇痛性疼痛缓解制剂、其制备和使用方法 |
-
2019
- 2019-10-23 CA CA3117213A patent/CA3117213A1/en active Pending
- 2019-10-23 JP JP2021547650A patent/JP2022509354A/ja not_active Ceased
- 2019-10-23 BR BR112021007692-1A patent/BR112021007692A2/pt not_active IP Right Cessation
- 2019-10-23 WO PCT/US2019/057722 patent/WO2020086759A2/en not_active Ceased
- 2019-10-23 CN CN201980085379.1A patent/CN113365513B/zh active Active
- 2019-10-23 EP EP19877023.2A patent/EP3869985A4/en not_active Withdrawn
- 2019-10-23 SG SG11202104158SA patent/SG11202104158SA/en unknown
- 2019-10-23 AU AU2019365216A patent/AU2019365216A1/en not_active Abandoned
- 2019-10-23 KR KR1020217015377A patent/KR20210119376A/ko not_active Ceased
- 2019-10-23 MX MX2021004692A patent/MX2021004692A/es unknown
- 2019-10-23 US US17/287,766 patent/US20220000966A1/en not_active Abandoned
- 2019-10-23 CN CN202510407573.4A patent/CN120285204A/zh active Pending
-
2021
- 2021-04-23 IL IL282600A patent/IL282600A/en unknown
- 2021-05-19 ZA ZA2021/03404A patent/ZA202103404B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022509354A5 (https=) | ||
| ES2780127T3 (es) | Formulación superfina de formoterol | |
| US8367734B1 (en) | Stable epinephrine suspension formulation with high inhalation delivery efficiency | |
| JP2022509354A (ja) | 肺を処置するための組成物および方法 | |
| SA04250122B1 (ar) | دواء جديد يحتوي على العامل المساعد بيتا 2 شديد الفعالية وطويل المفعول وذلك بالاتحاد مع مكونات فعاله أخرى | |
| JP3541060B2 (ja) | 生物学的活性物質を適用するためのエーロゾル圧力ガス充填物及びその製法 | |
| EP1915129A2 (en) | Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation | |
| WO2020160667A1 (en) | Nicotine aerosol formulation | |
| Dongare et al. | An overview of recently published patents on pulmonary drug delivery devices | |
| TW201350138A (zh) | 妥布黴素調配物 | |
| TWI818601B (zh) | 用於上呼吸道給藥之組成物及其用途 | |
| RU2021114377A (ru) | Композиция и способ для лечения легких | |
| US20220080020A1 (en) | Compositions and methods for reducing the transmissivity of illnesses using an oral delivery system | |
| US20150250779A1 (en) | Agent for Ameliorating Chronic Obstructive Pulmonary Disease | |
| CN103813798B (zh) | 从罗望子树的种子获得的多糖聚合物在防止烟草相关的损伤中的用途 | |
| WO2021211923A1 (en) | Compositions and methods for treating disease | |
| JP2023543965A (ja) | 吸入経路を介するソフトミスト吸入器又は振動メッシュ式ネブライザーによるウイルス性肺疾患、急性及び／又は慢性の肺疾患治療におけるヘパリン組成物の使用 | |
| TR2023012456A1 (tr) | İnhale edi̇lebi̇li̇r formda sivi bi̇leşi̇mler | |
| TR2023012447A1 (tr) | İti̇ci̇ gaz i̇çermeyen sivi farmasöti̇k bi̇leşi̇mler | |
| TR2024008687A1 (tr) | Solunabi̇li̇r formda n-aseti̇lsi̇stei̇n i̇çeren aerosol bi̇leşi̇mleri̇ | |
| TR2024003067A1 (tr) | İnhalasyon yoluyla kullanima uygun bi̇r fosfodi̇esteraz i̇nhi̇bi̇törü i̇çeren aerosol bi̇leşi̇mler | |
| TR2023014910A1 (tr) | Solunabi̇li̇r formda steroi̇d i̇çeren aerosol bi̇leşi̇mler | |
| TR2023016002A1 (tr) | İnhalasyona uygun steroi̇d bi̇r etken madde i̇çeren farmasöti̇k bi̇leşi̇mler | |
| TR2023014905A1 (tr) | Steroi̇d i̇çeren aerosol bi̇leşi̇mler | |
| WO2026011141A1 (en) | Compositions, devices and methods for respritory delivery of active pharmaceutical ingredients |